Mind Medicine To Raise Up To $100 Million Via ATM Financing

Mind Medicine (NEO: MMED) last night announced that it will be conducting a financing. The company is looking to raise funds via an at-the-market financing, which will be conducted on the Nasdaq Capital markets.

The financing will see the company raise up to $100.0 million via the offering, with shares to be sold directly on the Nasdaq. Shares under the program are not to be sold on a Canadian exchange or to those residing in Canada.

The company also indicated that it expects the offering to result in the issuance of up to 119.4 million shares, based on the firm trading at $0.84 at the time of the offering being filed. That however is subject to change, based upon the prevailing market prices at the time of the share sales.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

The offering is being conducted by Cantor Fitzgerald as well as Oppenheimer & Co.

While not stated directly in the news release, the company has indicated within its prospectus that the proceeds from the financing are to be used to fund the R&D of product candidates, to acquire or license products or tech, as well as for working capital and general corporate purposes.

The firm reported a cash position of $120.5 million as of March 31, 2022 within its latest financial results, which were filed last night.

Mind Medicine last traded at $1.00 on the Neo.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Mind Medicine To Conduct $25.0 Million Bought Deal Financing

Mind Medicine (CEO: MMED) announced that it will be conducting a bought deal financing this...

Friday, October 9, 2020, 09:01:05 AM

Mind Medicine Prices $30 Million Offering At 30% Discount To Market

Mind Medicine (NEO: MMED) has elected to destroy shareholder value in a major way this...

Wednesday, September 28, 2022, 09:28:04 AM

Canaccord Reiterates $1.75 Price Target For Mind Medicine Following Roadshow Event

This morning, Canaccord released a flash update for Mind Medicine (NEO: MMED) with highlights from...

Monday, September 28, 2020, 11:02:24 AM

Mind Medicine Closes The Year Out With Further Management Departures

Mind Medicine (NEO: MMED) has seen further management departures, following the departure of its CEO...

Wednesday, December 29, 2021, 08:38:09 AM

Mind Medicine Applies To List On The Nasdaq

Mind Medicine (NEO: MMED) this morning announced that it has submitted an application to uplist...

Monday, September 21, 2020, 07:53:31 AM